How to Talk to Your Doctor About Psychedelic Therapy

You’ve done the reading. You’ve watched the documentaries. You’ve maybe spent a few late nights going down research rabbit holes about psilocybin, ketamine, or MDMA-assisted therapy. And somewhere in all of that, you started wondering whether this could be relevant to your own life.

Then comes the harder part: bringing it up with your doctor.

For many people, talking to a doctor about psychedelic therapy feels like a risk. Will they dismiss you? Flag something in your chart? Think you’re just looking for a high? These concerns are understandable, and they’re also very common. This guide is here to help you move past them with a clear, grounded approach to the conversation.

Why the Conversation Is Worth Having

The clinical landscape around psychedelics has shifted considerably in recent years. Psilocybin has received Breakthrough Therapy designation from the FDA for treatment-resistant depression and major depressive disorder. Ketamine and its derivative esketamine (Spravato) are already FDA-approved and in clinical use. A growing number of psychiatrists and primary care physicians are either familiar with this research or actively following it.

According to a 2024 review published in Primary Care Companion CNS Disorders, attitudes among psychiatrists toward psychedelics as treatments have shifted significantly, with a striking increase in positive views documented between 2016 and 2022. Your doctor may be more open than you expect, especially if you come prepared.

The goal of the conversation is not to convince your doctor to prescribe you something. It is to open a collaborative dialogue about your treatment history, your current options, and whether a supported psychedelic experience might be worth exploring. That framing matters.

Before the Appointment: What to Prepare

Walking in with some preparation makes a real difference. Here’s what’s worth having ready.

A clear summary of your treatment history

List the treatments you’ve tried, when you tried them, and what the outcome was. Include medications, dosages, duration, and why you stopped if you did. If you’ve been through multiple antidepressants without satisfactory results, say so clearly. Your treatment history is the foundation of the conversation, and having it organized shows you’re approaching this seriously.

A few research anchors

You don’t need to print out a stack of PDFs, but having one or two peer-reviewed references can shift the tone of the conversation. The Imperial College London and Johns Hopkins psilocybin trials are well-documented and widely cited. If your concern is depression, the COMPASS Pathways Phase 2 trial is another relevant reference point. Framing the conversation around published research signals that your interest is grounded, not impulsive.

Your actual questions

Write them down. It’s easy to forget what you wanted to ask when you’re sitting across from someone in a clinical setting. Some useful questions to bring:

• Given my current medications, are there safety concerns I should know about before exploring psychedelic therapy?
• What would a supervised taper look like if that became relevant?
• Are you familiar with any providers or programs in this space you’d feel comfortable referring me to?
• Would you be willing to coordinate care if I worked with a psychedelic guide externally?

These are practical, collaborative questions. They position your doctor as a partner rather than a gatekeeper, which tends to produce better conversations.

How to Frame the Conversation Itself

The way you open matters. Starting with something like “I want to try mushrooms” lands differently than “I’ve been reading about psilocybin-assisted therapy and wanted to get your perspective given my treatment history.” The second version signals that you’re approaching this as a patient interested in evidence-based options, not someone looking for permission to experiment.

A practical opening script: “I’ve been reading about psychedelic-assisted therapy, particularly psilocybin, and I’m genuinely curious whether it could be relevant for me. I wanted to discuss it with you before I pursue anything, because I want to make sure I understand any medication interactions or safety considerations first.”

This opening does a few things. It names the intervention specifically. It positions your doctor as someone whose input you value. And it raises the medication question proactively, which is often the most clinically significant issue for anyone currently on psychiatric medication.

The SSRI Question: What You Actually Need to Know

If you are currently taking an SSRI or SNRI, this is likely where the conversation will get most substantive, and it is genuinely important territory.

The concern is pharmacological. SSRIs work in part by downregulating serotonin receptors, which are also the primary targets of psilocybin. There is reasonable clinical evidence that ongoing SSRI use may blunt the subjective and therapeutic effects of psilocybin. A 2024 study from Imperial College London (Erritzoe et al., published in the Journal of Psychopharmacology) examined patients who tapered serotonergic antidepressants before psilocybin therapy, using a gradual 2-to-4-week reduction protocol followed by at least a two-week washout period before treatment began.

However, the picture is more nuanced than a simple “stop your SSRIs” recommendation. A 2023 paper in Neuropsychopharmacology noted that SSRI discontinuation prior to psilocybin therapy introduces its own risks, including withdrawal symptoms and potential worsening of depression during the taper period. Some more recent clinical approaches are actively exploring whether psilocybin can be effective even in patients who remain on their medications. A 2025 consensus statement from the US National Network of Depression Centers noted that for some patients, tapering may not be clinically feasible, and that the decision requires individualized evaluation by a knowledgeable provider.

The practical takeaway: do not taper or stop any medication on your own. The SSRI taper psilocybin question is genuinely complex, and it is exactly the kind of thing your prescribing physician needs to be part of. If they’re not comfortable managing it themselves, asking for a referral to someone who is more familiar with this area is entirely reasonable.

What If Your Doctor Is Skeptical or Unfamiliar?

Not every physician will respond positively, and that’s worth being prepared for.

If your doctor is unfamiliar with the research, that’s an opportunity rather than a dead end. Offering to share a specific paper or two after the appointment keeps the conversation open without putting them on the spot in the moment. Framing it as “here’s what I’ve been reading, and I’d love your perspective on it” invites dialogue rather than debate.

If your doctor is skeptical, try to understand what their specific concern is. Is it legal status? Safety? Lack of evidence? Each of these has a substantive response, and understanding their objection lets you address it more precisely. You might also ask whether they’d be open to a conversation with a colleague who works in this space, or whether they’d be willing to coordinate with an external provider if you pursued a supported experience separately.

If the conversation shuts down completely, that’s also useful information. It may mean you need a different provider for this part of your care, or that talking to a specialist in psychedelic-assisted therapy first would give you better clinical grounding to bring back to your existing doctor.

The Role of a Concierge Guide

This is where working with a professional guide becomes particularly valuable. A good guide doesn’t replace your doctor. They work alongside your existing care team, helping you prepare for the experience, navigate the conversation with your prescriber, and integrate what comes up afterward.

At JourneyŌM, this kind of coordination is built into the process. Before anything else happens, there’s a thorough intake to understand your full medical and psychological history, including any current medications. If you’re on an SSRI and wondering how to discuss psilocybin with your psychiatrist, that’s exactly the kind of question a concierge consultation can help you think through clearly, before you walk into that appointment.

The goal is continuity of care. Not a single session in isolation, but a supported process with someone who understands both the clinical landscape and the practical realities of navigating it.

A Few Things Worth Saying Directly

Talking to your doctor about psychedelic therapy is not asking for permission to do something risky and unsupervised. It is doing the responsible thing: surfacing your interest with your prescriber, understanding the medical considerations, and building a care picture that includes everyone who needs to be in it.

You deserve a doctor who can engage with this seriously. If yours can’t, that’s worth knowing. And if you’re not sure where to start, a conversation with someone who specializes in this space can help you walk into that appointment with more clarity and confidence.